120321-65-5 Usage
Description
4-Butylamino-3-nitro-benzoic acid is a chemical compound with a molecular formula C11H13NO4. It is a derivative of benzoic acid, characterized by a butylamino group and a nitro group attached to a benzene ring. This unique structure provides it with distinctive chemical properties, making it a valuable reagent in organic synthesis and a promising candidate for various applications in the fields of medicine, materials science, and pharmaceuticals.
Uses
Used in Pharmaceutical Industry:
4-Butylamino-3-nitro-benzoic acid is used as an intermediate in the synthesis of pharmaceuticals for its unique chemical properties. It aids in the development of new drugs and contributes to the advancement of medicine.
Used in Dyes Production:
In the dyes industry, 4-Butylamino-3-nitro-benzoic acid is used as a key component in the production of various dyes. Its chemical structure allows for the creation of a wide range of colors and properties, enhancing the versatility and effectiveness of dyes.
Used in Materials Science:
4-Butylamino-3-nitro-benzoic acid is utilized in materials science for its potential applications in developing new materials with unique properties. Its structure and reactivity make it a valuable tool for researchers and chemists in creating innovative materials for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 120321-65-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,3,2 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 120321-65:
(8*1)+(7*2)+(6*0)+(5*3)+(4*2)+(3*1)+(2*6)+(1*5)=65
65 % 10 = 5
So 120321-65-5 is a valid CAS Registry Number.
120321-65-5Relevant articles and documents
Synthesis and biological evaluation of novel dabigatran derivatives as thrombin inhibitors
Li, Chun Lei,Ren, Yu Jie
, p. 735 - 752 (2016)
A novel series of 3-[{2-[(4-carbamimidoylphenylamino)methyl]-1-substituted-1H-benzoimidazole-5-carbonyl}(3-chloro-4-fluorophenyl)amino]propionic derivatives of dabigatran was synthesized. The structures of the compounds were characterized by 1H NMR, 13C NMR, HRMS, and elemental analysis. The compounds were screened for in vitro thrombin inhibitory activity. The results indicated that the compounds had low to moderate inhibitory activity. The compounds with N-methyl and N-ethyl side chains had much greater inhibitory activity against thrombin than those with other side chains.
Halogen substituents on the aromatic moiety of the tetracaine scaffold improve potency of cyclic nucleotide-gated channel block
Kirk, Sarah R.,Jackson, Evan P.,Cuellar, Elysia,Andrade, Adriana L.,Melich, Kenneth,Karpen, Jeffrey W.
supporting information; experimental part, p. 6417 - 6419 (2011/12/02)
A series of new tetracaine derivatives with substituents on the aromatic ring was prepared and evaluated for block of retinal rod cyclic nucleotide-gated (CNG) channels. Aromatic substitutions had little effect starting with the basic tetracaine scaffold,
(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
-
, (2008/06/13)
(1_H-azol-1-ylmethyl)substituted benzotriazole derivatives, compositions containing the same, and methods of treating estrogen dependent disorders.
